Evidence map›Paper›PMID 42326976›Full record

ArticleAmerican journal of ophthalmology case reports2026

Peripheral nodulocystic corneal degeneration: a case report.

Mariana Arino, Maria Lee, Jillian Chong, Madeline Yung

Abstract readCase Reports
In one paragraph

Article in American journal of ophthalmology case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mariana ArinoDepartment of Ophthalmology, University of California, San Francisco, CA, USA.
Maria LeeDepartment of Ophthalmology, University of California, San Francisco, CA, USA.
Jillian ChongBeverly Hills Institute of Ophthalmology, USA.
Madeline YungDepartment of Ophthalmology, University of California, San Francisco, CA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Purpose: Peripheral nodulocystic corneal degeneration (PNCD) is a rare and poorly understood corneal degeneration. We report a case most consistent with PNCD in a patient with a remote history of conventional laser-assisted in situ keratomileusis (LASIK) and multiple systemic inflammatory conditions. Observation: A 52-year-old woman with a medical history of multiple systemic arthralgias and an ocular history of bilateral LASIK presented with progressive left eye dryness and discomfort. Ocular examination revealed multiple bullous corneal nodules in both eyes, predominantly in the superior and temporal periphery of the cornea. Anterior segment optical coherence tomography (AS-OCT) revealed subepithelial cystoid spaces with Bowman's Membrane disruption, and specular microscopy showed mild endothelial cell loss with polymegethism and pleomorphism. The clinical findings were most consistent with peripheral nodulocystic degeneration (PNCD). She declined superficial keratectomy, and her symptoms improved with topical cyclosporine, perfluorohexyloctane, and brimonidine. Conclusion and importance: We describe a case of lucent peripheral corneal bullae most consistent with PNCD, of which only one similar case has been previously reported in the literature. PNCD appears to be an indolent, slowly progressive corneal degeneration. This case highlights a unique presentation of corneal degeneration and cause of peripheral corneal bullae. The interplay between corneal degeneration, systemic inflammatory disease, and prior refractive surgery warrants further investigation.

Indexed as

Corneal degenerative disordersCorneal edemaCorneal nodulesPeripheral nodulocystic corneal degeneration

Identifiers

PMID42326976
PMCPMC13276531

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.